Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00004340 · ClinicalTrials.gov registry record · Phase 2

Phase II Randomized Study of the Effects of Growth Hormone on Children and Adolescents on Maintenance Dialysis

A Phase 2 study of End Stage Renal Disease and Renal Osteodystrophy, sponsored by National Center for Research Resources (NCRR).

Completed
Registry status
Phase 2
Development phase
109
Enrollment target
1
Study location

NCT00004340 is a Phase 2 study of End Stage Renal Disease and Renal Osteodystrophy that has completed, run by National Center for Research Resources (NCRR). The registered enrollment target is 109 participants, below the 832-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00004340, a Phase 2 study of End Stage Renal Disease and Renal Osteodystrophy, has completed, sponsored by National Center for Research Resources (NCRR).

COMPLETED
Registry status
Phase 2
Development phase
109 participants
Enrollment target
1
Study location

Study Summary

OBJECTIVES: I. Evaluate the separate and combined skeletal effects of recombinant human growth hormone (GH) and calcitriol in patients with adynamic renal osteodystrophy. II. Assess whether calcium-regulated changes in parathyroid hormone secretion predict changes in bone formation. III. Characterize the response to GH in cancellous bone and in growth plate cartilage in patients with secondary hyperparathyroidism during calcitriol therapy.

Conditions Studied

End Stage Renal Disease Renal Osteodystrophy

Interventions

  • DRUG growth hormone
  • DRUG calcitriol

Study Locations (1)

California

  • University of California Los Angeles School of Medicine - Los Angeles

Trial Details

FieldValue
Enrollment Target 109 participants
Start Date 1995-06
Phase Phase 2

Sponsor

National Center for Research Resources (NCRR)

94 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00004340

The ClinicalTrials.gov registry entry for NCT00004340 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 109 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 832-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (87% lower). The listed sponsor is National Center for Research Resources (NCRR), which has 94 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with End Stage Renal Disease appearing as the primary indexed condition, and to 2 interventions - of which growth hormone is the first listed.

NCT00004340 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00004340 about?

NCT00004340 is a clinical study titled "Phase II Randomized Study of the Effects of Growth Hormone on Children and Adolescents on Maintenance Dialysis". OBJECTIVES: I. Evaluate the separate and combined skeletal effects of recombinant human growth hormone (GH) and calcitriol in patients with adynamic renal osteodystrophy. II. Assess whether calcium-regulated changes in parathyroid hormone secretion predict changes in bone formation. III. Character...

What is the current status of trial NCT00004340?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 109 participants. The study started on 1995-06.

What conditions does trial NCT00004340 study?

This clinical trial studies the following conditions: End Stage Renal Disease, Renal Osteodystrophy.

What interventions are being tested in trial NCT00004340?

The interventions under investigation include: growth hormone (DRUG), calcitriol (DRUG).

Who is sponsoring clinical trial NCT00004340?

This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00004340 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for End Stage Renal Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

End Stage Renal Disease

All registered trials for this condition

Renal Osteodystrophy

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.